 Liposomal encapsulation AZT results decreased bone marrow toxicity enhanced activity murine AIDS-induced immunosuppression effect liposome encapsulation bone marrow toxicity antiviral activity AZT mice Liposomal encapsulation AZT localization liver spleen lung reduced localization bone marrow AZT i.v mg/kg/day significant bone marrow toxicity reduction cellularity injections maximum toxicity equal mg/kg/day Parallel reductions number erythrocytes leukocytes AZT liposomes bone marrow toxicity doses mg/kg/day erythrocyte leukocyte numbers normal Infection mice murine leukemia virus T- B-cell mitogenic responses Treatment retrovirus-infected mice mg/kg AZT times weekly mitogenic response weeks postinfection Treatment liposomal AZT normal T- B-cell mitogenic responses weeks postinfection